Jill E. Sackman, PhD

Bio/pharmaceutical manufacturers in the UK face challenges in proving that their drugs are worth the price.

The authors take a look at some of the recent developments in the German pharmaceutical market.

The authors take a look at some of the recent developments in the German pharmaceutical market.

Data analytic strategies can help companies capitalize on personalized medicine.

An established drug-manufacturing base with quality and safety issues, and patent protection and price capping concerns complicate efforts to do business in India.

Biopharma companies should not overlook India's growing market.

The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.

Israel's diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R&D, clinical research, and market growth.

The pharmaceutical industry grows despite conflict in the Middle East.

The bio-pharmaceutical business outlook in South Korea remains positive.

A unique demographic and payer mix make ASEAN an increasingly attractive region.

Latin America's diverse growing market seeks regulatory harmonization.